Cargando…
Targeting EFNA1 suppresses tumor progression via the cMYC-modulated cell cycle and autophagy in esophageal squamous cell carcinoma
PURPOSE: Esophageal squamous cell carcinoma (ESCC) remains one of the most common causes of cancer death due to the lack of effective therapeutic options. New targets and the targeted drugs are required to be identified and developed. METHODS: Highly expressed genes in ESCA were identified using the...
Autores principales: | Jiang, Houxiang, Wang, Shaoxiang, Liu, Ying, Zheng, Chaopan, Chen, Lipeng, Zheng, Kai, Xu, Zhenyu, Dai, Yong, Jin, Hongtao, Cheng, Zhiqiang, Zou, Chang, Fu, Li, Liu, Kaisheng, Ma, Xiaoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169935/ https://www.ncbi.nlm.nih.gov/pubmed/37160815 http://dx.doi.org/10.1007/s12672-023-00664-9 |
Ejemplares similares
-
Effects of EFNA1 on cell phenotype and prognosis of esophageal carcinoma
por: Zhang, Yongqiang, et al.
Publicado: (2021) -
Transformation of normal cells by aberrant activation of YAP via cMyc with TEAD
por: Nishimoto, Masazumi, et al.
Publicado: (2019) -
A proteomic study of cMyc improvement of CHO culture
por: Kuystermans, Darrin, et al.
Publicado: (2010) -
Temporal Requirements of cMyc Protein for Reprogramming Mouse Fibroblasts
por: Heffernan, Corey, et al.
Publicado: (2012) -
Loss of MYSM1 inhibits the oncogenic activity of cMYC in B cell lymphoma
por: Lin, Yun Hsiao, et al.
Publicado: (2021)